Item
Vanadium Aspartate 0.1% R13383 K (WS-81912)
Vanadium Aspartate, Sodium Sulfate, Aspartic Acid
Mineral / Salt
Attributes
- Gluten-free
- Ingredient declaration
Locations
Location name | Address |
---|---|
WRIGHT PHARMA, INC. | 700 Kiernan Ave. Ste. A Modesto, CA 95356 |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | WRIGHT PHARMA, INC. | Allergens.pdf | 10/10/2024 | 10/10/2026 |
Country of Origin | WRIGHT PHARMA, INC. | Country of Origin.pdf | 11/10/2022 | 11/9/2025 |
National Bioengineered Food Disclosure Standard (Simplified) | WRIGHT PHARMA, INC. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 11/10/2022 | 11/9/2025 |
Nutrition | WRIGHT PHARMA, INC. | Nutrition.pdf | 7/19/2023 | 7/18/2026 |
BSE - TSE | WRIGHT PHARMA, INC. | WS-81912 BSE Statement.pdf | 11/10/2022 | 11/9/2025 |
Gluten | WRIGHT PHARMA, INC. | WS-81912 Gluten Statement.pdf | 10/3/2024 | 10/3/2026 |
GRAS/NDI/ODI Statement | WRIGHT PHARMA, INC. | WS-81912 GRAS Statement.pdf | 7/15/2024 | 7/15/2027 |
Halal | WRIGHT PHARMA, INC. | WS-81912 Halal Compliance.pdf | 11/10/2022 | 11/30/2023 |
Ingredient Statement | WRIGHT PHARMA, INC. | WS-81912 Ingredients Composition Range.pdf | 11/10/2022 | 11/10/2023 |
Kosher | WRIGHT PHARMA, INC. | WS-81912 Kosher.pdf | 11/10/2022 | 11/30/2023 |
GMO | WRIGHT PHARMA, INC. | WS-81912 Non-GMO Statement.pdf | 11/10/2022 | 11/9/2024 |
EtO Statement | WRIGHT PHARMA, INC. | WS-81912 Organic Declaration.pdf | 11/10/2022 | 11/30/2023 |
Irradiation Status Statement | WRIGHT PHARMA, INC. | WS-81912 Organic Declaration.pdf | 10/11/2024 | 10/11/2026 |
Sewage Statement | WRIGHT PHARMA, INC. | WS-81912 Organic Declaration.pdf | 10/11/2024 | 10/11/2026 |
California Prop. 65 | WRIGHT PHARMA, INC. | WS-81912 Prop 65 Statement.pdf | 10/11/2024 | 10/11/2026 |
Pesticide | WRIGHT PHARMA, INC. | WS-81912 Residual Pesticide Statement.pdf | 11/10/2022 | 11/9/2024 |
Residual Statement | WRIGHT PHARMA, INC. | WS-81912 Residual Pesticide Statement.pdf | 11/14/2022 | 11/14/2023 |
Safety Data Sheet (SDS) | WRIGHT PHARMA, INC. | WS-81912 Vanadium Aspartate 0.1% SDS.pdf | 10/10/2024 | 10/10/2027 |
Vegan/Vegetarian Statement | WRIGHT PHARMA, INC. | WS-81912 Vegan Statement.pdf | 11/14/2023 | 11/13/2025 |
WADA/NSF/NFL Statement | WRIGHT PHARMA, INC. | WS-81912 WADA Statement.pdf | 11/10/2022 | 11/30/2023 |